Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma

Annelies Nijdam; Nicky Dekker; Berthe M. P. Aleman; Mars B. van't Veer; Laurien A. Daniels; Richard W. van der Maazen; Cecile P. M. Janus; Roel J. de Weijer; Josee M. Zijlstra; Floriske G. Stedema; Bastiaan D. Ta; Eduardus F. M. Posthuma; Annelies Manenschijn; Michel F. H. Dielwart; Yavuz M. Bilgin; Maaike J. van den Heuvel; Rinske S. Boersma; Flora E. van Leeuwen; John M. M. Raemaekers; BETER consortium

doi:10.1111/bjh.15936

Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma

Annelies Nijdam, Nicky Dekker, Berthe M. P. Aleman, Mars B. van't Veer, Laurien A. Daniels, Richard W. van der Maazen, Cecile P. M. Janus, Roel J. de Weijer, Josee M. Zijlstra, Floriske G. Stedema, Bastiaan D. Ta, Eduardus F. M. Posthuma, Annelies Manenschijn, Michel F. H. Dielwart, Yavuz M. Bilgin, Maaike J. van den Heuvel, Rinske S. Boersma, Flora E. van Leeuwen^*, John M. M. Raemaekers, BETER consortium

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	E103-E108
Number of pages	6
Journal	British Journal of Haematology
Volume	186
Issue number	4
DOIs	https://doi.org/10.1111/bjh.15936
Publication status	Published - Aug 2019

Keywords

Hodgkin lymphoma
long-term adverse effects
survivorship care
screening guidelines
CHILDHOOD-CANCER
BREAST-CANCER
RECOMMENDATIONS
SURVEILLANCE
PROGRAMS

Access to Document

10.1111/bjh.15936

https://pure.rug.nl/ws/files/97127287/Nijdam_et_al_2019_British_Journal_of_Haematology.pdfLicence: Other

Cite this

Nijdam, A., Dekker, N., Aleman, B. M. P., van't Veer, M. B., Daniels, L. A., van der Maazen, R. W., Janus, C. P. M., de Weijer, R. J., Zijlstra, J. M., Stedema, F. G., Ta, B. D., Posthuma, E. F. M., Manenschijn, A., Dielwart, M. F. H., Bilgin, Y. M., van den Heuvel, M. J., Boersma, R. S., van Leeuwen, F. E., Raemaekers, J. M. M., & BETER consortium (2019). Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma. British Journal of Haematology, 186(4), E103-E108. https://doi.org/10.1111/bjh.15936

@article{487b6cc63d3047708c0278bc291c1f86,

title = "Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma",

keywords = "Hodgkin lymphoma, long-term adverse effects, survivorship care, screening guidelines, CHILDHOOD-CANCER, BREAST-CANCER, RECOMMENDATIONS, SURVEILLANCE, PROGRAMS",

author = "Annelies Nijdam and Nicky Dekker and Aleman, {Berthe M. P.} and {van't Veer}, {Mars B.} and Daniels, {Laurien A.} and {van der Maazen}, {Richard W.} and Janus, {Cecile P. M.} and {de Weijer}, {Roel J.} and Zijlstra, {Josee M.} and Stedema, {Floriske G.} and Ta, {Bastiaan D.} and Posthuma, {Eduardus F. M.} and Annelies Manenschijn and Dielwart, {Michel F. H.} and Bilgin, {Yavuz M.} and {van den Heuvel}, {Maaike J.} and Boersma, {Rinske S.} and {van Leeuwen}, {Flora E.} and Raemaekers, {John M. M.} and {BETER consortium}",

note = "Funding Information: This work was supported by the Van Vlissingen Lymphoma Fund [grant number NKI-AVL-58256]; Dutch Cancer Society-Alpe d'HuZes [grant number NKI 2011-5270]; and Pink Ribbon [grant number 2010.PS05.C68]. For their contribution to the development of the BETER guidelines we are greatly indebted to dr. E. Sieswerda of the Department of Medical Microbiology and Infection Control at the VU University Medical Centre in Amsterdam and dr. W.E. Kok of the Department of Cardiology at the Academic Medical Centre in Amsterdam. Funding Information: This work was supported by the Van Vlissingen Lymphoma Fund [grant number NKI-AVL-58256]; Dutch Cancer Society-Alpe d{\textquoteright}HuZes [grant number NKI 2011-5270]; and Pink Ribbon [grant number 2010.PS05.C68]. For their contribution to the development of the BETER guidelines we are greatly indebted to dr. E. Sieswerda of the Department of Medical Microbiology and Infection Control at the VU University Medical Centre in Amsterdam and dr. W.E. Kok of the Department of Cardiology at the Academic Medical Centre in Amsterdam.",

year = "2019",

month = aug,

doi = "10.1111/bjh.15936",

language = "English",

volume = "186",

pages = "E103--E108",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley & Sons Inc.",

number = "4",

}

Nijdam, A, Dekker, N, Aleman, BMP, van't Veer, MB, Daniels, LA, van der Maazen, RW, Janus, CPM, de Weijer, RJ, Zijlstra, JM, Stedema, FG, Ta, BD, Posthuma, EFM, Manenschijn, A, Dielwart, MFH, Bilgin, YM, van den Heuvel, MJ, Boersma, RS, van Leeuwen, FE, Raemaekers, JMM & BETER consortium 2019, 'Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma', British Journal of Haematology, vol. 186, no. 4, pp. E103-E108. https://doi.org/10.1111/bjh.15936

TY - JOUR

T1 - Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma

AU - Nijdam, Annelies

AU - Dekker, Nicky

AU - Aleman, Berthe M. P.

AU - van't Veer, Mars B.

AU - Daniels, Laurien A.

AU - van der Maazen, Richard W.

AU - Janus, Cecile P. M.

AU - de Weijer, Roel J.

AU - Zijlstra, Josee M.

AU - Stedema, Floriske G.

AU - Ta, Bastiaan D.

AU - Posthuma, Eduardus F. M.

AU - Manenschijn, Annelies

AU - Dielwart, Michel F. H.

AU - Bilgin, Yavuz M.

AU - van den Heuvel, Maaike J.

AU - Boersma, Rinske S.

AU - van Leeuwen, Flora E.

AU - Raemaekers, John M. M.

AU - BETER consortium

N1 - Funding Information: This work was supported by the Van Vlissingen Lymphoma Fund [grant number NKI-AVL-58256]; Dutch Cancer Society-Alpe d'HuZes [grant number NKI 2011-5270]; and Pink Ribbon [grant number 2010.PS05.C68]. For their contribution to the development of the BETER guidelines we are greatly indebted to dr. E. Sieswerda of the Department of Medical Microbiology and Infection Control at the VU University Medical Centre in Amsterdam and dr. W.E. Kok of the Department of Cardiology at the Academic Medical Centre in Amsterdam. Funding Information: This work was supported by the Van Vlissingen Lymphoma Fund [grant number NKI-AVL-58256]; Dutch Cancer Society-Alpe d’HuZes [grant number NKI 2011-5270]; and Pink Ribbon [grant number 2010.PS05.C68]. For their contribution to the development of the BETER guidelines we are greatly indebted to dr. E. Sieswerda of the Department of Medical Microbiology and Infection Control at the VU University Medical Centre in Amsterdam and dr. W.E. Kok of the Department of Cardiology at the Academic Medical Centre in Amsterdam.

PY - 2019/8

Y1 - 2019/8

KW - Hodgkin lymphoma

KW - long-term adverse effects

KW - survivorship care

KW - screening guidelines

KW - CHILDHOOD-CANCER

KW - BREAST-CANCER

KW - RECOMMENDATIONS

KW - SURVEILLANCE

KW - PROGRAMS

U2 - 10.1111/bjh.15936

DO - 10.1111/bjh.15936

M3 - Comment/Letter to the editor

C2 - 31090916

SN - 0007-1048

VL - 186

SP - E103-E108

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 4

ER -